busulfan has been researched along with Hemorrhage in 49 studies
Hemorrhage: Bleeding or escape of blood from a vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Therapeutic options for patients with polycythemia vera (PV) and essential thrombocythemia (ET) resistant or intolerant to hydroxyurea are limited." | 9.19 | Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea. ( Alvarez-Larrán, A; Ancochea, A; Angona, A; Antelo, ML; Bellosillo, B; Besses, C; Burgaleta, C; Cervantes, F; Durán, MA; Ferrer-Marín, F; Gómez, M; Gómez-Casares, MT; Hernández-Boluda, JC; Marcote, B; Martínez-Avilés, L; Martínez-Trillos, A; Mata, MI; Senín, A; Vicente, V; Xicoy, B, 2014) |
| " From 1974 to 1986 we treated 20 symptomatic ET patients with microvascular circulation disturbances including erythromelalgia (N = 18), atypical or typical transient ischemic attacks (N = 6), or acute coronary ischemic syndrome (N = 3) with aspirin and one course of busulfan." | 9.09 | Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia. ( Michiels, JJ, 1999) |
| "High dose cyclophosphamide and/or busulfan conditioning treatment of recipients of bone marrow transplants proved to be highly effective but associated with substantial and sometimes life threatening hemorrhagic cystitis." | 7.69 | Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. ( Abella, E; Haas, GP; Karanes, C; Lum, LG; Momin, F; Sensenbrenner, LL; Turkeri, LN; Uberti, JP, 1995) |
| "We report a case of severe hemorrhagic cystitis induced by prolonged busulfan therapy." | 7.66 | Busulfan-induced hemorrhagic cystitis. ( Perlberg, S; Pode, D; Steiner, D, 1983) |
| "A case of a busulfan-induced hemorrhage cystitis is reported." | 7.66 | Busulfan-induced hemorrhagic cystitis. ( Millard, RJ, 1981) |
| "Therapeutic options for patients with polycythemia vera (PV) and essential thrombocythemia (ET) resistant or intolerant to hydroxyurea are limited." | 5.19 | Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea. ( Alvarez-Larrán, A; Ancochea, A; Angona, A; Antelo, ML; Bellosillo, B; Besses, C; Burgaleta, C; Cervantes, F; Durán, MA; Ferrer-Marín, F; Gómez, M; Gómez-Casares, MT; Hernández-Boluda, JC; Marcote, B; Martínez-Avilés, L; Martínez-Trillos, A; Mata, MI; Senín, A; Vicente, V; Xicoy, B, 2014) |
| " From 1974 to 1986 we treated 20 symptomatic ET patients with microvascular circulation disturbances including erythromelalgia (N = 18), atypical or typical transient ischemic attacks (N = 6), or acute coronary ischemic syndrome (N = 3) with aspirin and one course of busulfan." | 5.09 | Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia. ( Michiels, JJ, 1999) |
| "High dose cyclophosphamide and/or busulfan conditioning treatment of recipients of bone marrow transplants proved to be highly effective but associated with substantial and sometimes life threatening hemorrhagic cystitis." | 3.69 | Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. ( Abella, E; Haas, GP; Karanes, C; Lum, LG; Momin, F; Sensenbrenner, LL; Turkeri, LN; Uberti, JP, 1995) |
| "We report a case of severe hemorrhagic cystitis induced by prolonged busulfan therapy." | 3.66 | Busulfan-induced hemorrhagic cystitis. ( Perlberg, S; Pode, D; Steiner, D, 1983) |
| "A case of a busulfan-induced hemorrhage cystitis is reported." | 3.66 | Busulfan-induced hemorrhagic cystitis. ( Millard, RJ, 1981) |
| "Erythromelalgia was localized in the forefoot sole and toes in 28, the fingertips in 9, the handpalm in 2." | 2.39 | Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia. ( Lindemans, J; Michiels, JJ; van Genderen, PJ; van Vliet, HH, 1996) |
| "Aspirin (ASS) was the most frequently used drug in 47 of 93 recorded cases (51%)." | 2.39 | Essential thrombocythemia and pregnancy. ( Griesshammer, M; Heimpel, H; Pearson, TC, 1996) |
| "The risk of major thrombosis is higher in ET patients aged more than 60 ys." | 2.39 | Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers. ( Barbui, T; Brière, J; Dupuy, E; Finazzi, G; Kiladjian, JJ, 1996) |
| "Risk of thrombosis is higher in JAK2-mutated ET." | 1.51 | Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. ( Barbui, T; Tefferi, A, 2019) |
| "Busulfan treatment did not affect edema and hemorrhage in P-selectin- or PSGL-1-deficient mice, suggesting that the effect by busulfan is dependent on P-selectin and PSGL-1 expression." | 1.36 | Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction. ( Fujimoto, M; Hara, T; Hasegawa, M; Iwata, Y; Komura, K; Muroi, E; Ogawa, F; Sato, S; Shimizu, K; Takenaka, M; Yanaba, K, 2010) |
| "Mesna possibly has a toxic effect on bladder mucosa." | 1.32 | Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. ( Hattori, K; Hotta, T; Inoue, H; Kato, S; Kawada, H; Kishi, K; Matsumoto, M; Ogawa, Y; Ohmachi, K; Shimizu, T; Tsuboi, K; Watanabe, S; Yabe, H; Yabe, M; Yasuda, Y; Yoshiba, F, 2003) |
| "Haemorrhagic cystitis is a common and often debilitating complication of chemotherapy for which treatment is frequently unsatisfactory." | 1.30 | Hyperbaric oxygen in the treatment of refractory haemorrhagic cystitis. ( Hughes, AJ; Millar, IL; Schwarer, AP, 1998) |
| "Bleeding and thrombosis are frequent complications in myeloproliferative disorders (MPD) and are associated with severe organ damage and a high mortality." | 1.28 | Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. ( Daum, I; Jamin, H; Schneider, W; Wehmeier, A, 1991) |
| "One characteristic of experimental allergic encephalomyelitis (EAE) in all species is the presence of a considerable leukocyte infiltrate in the central nervous system (CNS)." | 1.27 | Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. ( Brostoff, S; Mason, D; Sedgwick, J, 1987) |
| " Thus, we have developed a safe chemotherapy schedule for transplantation that avoids the need for radiotherapy and can, if necessary, be repeated after a 3-month interval." | 1.27 | Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children. ( Barnes, R; Downie, CJ; Hobbs, JR; Hugh-Jones, K; Shaw, PJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (48.98) | 18.7374 |
| 1990's | 15 (30.61) | 18.2507 |
| 2000's | 5 (10.20) | 29.6817 |
| 2010's | 4 (8.16) | 24.3611 |
| 2020's | 1 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Santos Carreira, A | 1 |
| Salas, MQ | 1 |
| Remberger, M | 2 |
| Novitzky-Basso, I | 1 |
| Law, AD | 1 |
| Lam, W | 1 |
| Pasic, I | 1 |
| Mazzulli, T | 1 |
| Cserti-Gazdewich, C | 1 |
| Kim, DDH | 1 |
| Michelis, FV | 1 |
| Viswabandya, A | 1 |
| Gerbitz, A | 1 |
| Lipton, JH | 1 |
| Kumar, R | 1 |
| Hassan, M | 2 |
| Mattsson, J | 2 |
| Törlen, J | 1 |
| Serafi, IE | 1 |
| Garming-Legert, K | 1 |
| Björklund, A | 1 |
| Ljungman, P | 1 |
| Sundin, M | 1 |
| Tefferi, A | 1 |
| Barbui, T | 3 |
| Alvarez-Larrán, A | 1 |
| Martínez-Avilés, L | 1 |
| Hernández-Boluda, JC | 1 |
| Ferrer-Marín, F | 1 |
| Antelo, ML | 1 |
| Burgaleta, C | 1 |
| Mata, MI | 1 |
| Xicoy, B | 1 |
| Martínez-Trillos, A | 1 |
| Gómez-Casares, MT | 1 |
| Durán, MA | 1 |
| Marcote, B | 1 |
| Ancochea, A | 1 |
| Senín, A | 1 |
| Angona, A | 1 |
| Gómez, M | 1 |
| Vicente, V | 1 |
| Cervantes, F | 1 |
| Bellosillo, B | 1 |
| Besses, C | 1 |
| Hara, T | 1 |
| Shimizu, K | 1 |
| Ogawa, F | 1 |
| Yanaba, K | 1 |
| Iwata, Y | 1 |
| Muroi, E | 1 |
| Takenaka, M | 1 |
| Komura, K | 1 |
| Hasegawa, M | 1 |
| Fujimoto, M | 1 |
| Sato, S | 1 |
| WEBB, AT | 1 |
| MEYER, FL | 1 |
| LONSER, ER | 1 |
| BRODY, JI | 1 |
| MCKENZIE, D | 1 |
| KIMBALL, SG | 1 |
| MATSUOKA, M | 1 |
| MOLANDER, DW | 1 |
| LADUE, JS | 1 |
| BANERJEA, JC | 1 |
| MUKHERJEE, SK | 1 |
| Tsuboi, K | 1 |
| Kishi, K | 1 |
| Ohmachi, K | 1 |
| Yasuda, Y | 1 |
| Shimizu, T | 1 |
| Inoue, H | 1 |
| Matsumoto, M | 1 |
| Hattori, K | 1 |
| Yoshiba, F | 1 |
| Watanabe, S | 1 |
| Ogawa, Y | 1 |
| Kawada, H | 1 |
| Yabe, H | 1 |
| Yabe, M | 1 |
| Kato, S | 1 |
| Hotta, T | 1 |
| Asano, Y | 1 |
| Kanda, Y | 1 |
| Ogawa, N | 1 |
| Sakata-Yanagimoto, M | 1 |
| Nakagawa, M | 1 |
| Kawazu, M | 1 |
| Goyama, S | 1 |
| Kandabashi, K | 1 |
| Izutsu, K | 1 |
| Imai, Y | 1 |
| Hangaishi, A | 1 |
| Kurokawa, M | 1 |
| Tsujino, S | 1 |
| Ogawa, S | 1 |
| Aoki, K | 1 |
| Chiba, S | 1 |
| Motokura, T | 1 |
| Hirai, H | 1 |
| Pode, D | 1 |
| Perlberg, S | 1 |
| Steiner, D | 1 |
| Millard, RJ | 1 |
| Turkeri, LN | 1 |
| Lum, LG | 1 |
| Uberti, JP | 1 |
| Abella, E | 1 |
| Momin, F | 1 |
| Karanes, C | 1 |
| Sensenbrenner, LL | 1 |
| Haas, GP | 1 |
| van Genderen, PJ | 2 |
| Michiels, JJ | 3 |
| Bernaudin, F | 1 |
| Souillet, G | 1 |
| Vannier, JP | 1 |
| Plouvier, E | 1 |
| Lemerle, S | 1 |
| Michel, G | 1 |
| Bordigoni, P | 1 |
| Lutz, P | 1 |
| Kuentz, M | 1 |
| Erer, B | 1 |
| Angelucci, E | 1 |
| Baronciani, D | 1 |
| Tomasucci, M | 1 |
| Giardini, C | 1 |
| Gaziev, J | 1 |
| Lindemans, J | 1 |
| van Vliet, HH | 1 |
| Griesshammer, M | 1 |
| Heimpel, H | 1 |
| Pearson, TC | 1 |
| Finazzi, G | 2 |
| Dupuy, E | 1 |
| Kiladjian, JJ | 1 |
| Brière, J | 1 |
| Hughes, AJ | 1 |
| Schwarer, AP | 1 |
| Millar, IL | 1 |
| Randi, ML | 2 |
| Rossi, C | 2 |
| Fabris, F | 2 |
| Menapace, L | 1 |
| Girolami, A | 2 |
| Zhu, K | 1 |
| Xu, Y | 1 |
| Wu, D | 1 |
| Xu, X | 1 |
| Huang, L | 1 |
| Leung, AY | 1 |
| Mak, R | 1 |
| Lie, AK | 1 |
| Yuen, KY | 1 |
| Cheng, VC | 1 |
| Liang, R | 1 |
| Kwong, YL | 1 |
| Whittaker, JA | 1 |
| Khurshid, M | 1 |
| Grossi, A | 1 |
| Vannucchi, AM | 1 |
| Longo, G | 1 |
| Rafanelli, D | 1 |
| Rossi Ferrini, P | 1 |
| Romeiras, M | 1 |
| Rodrigues, AS | 1 |
| Machado, A | 1 |
| Jorge, L | 1 |
| Nolasco, I | 1 |
| Abecasis, M | 1 |
| Wehmeier, A | 1 |
| Daum, I | 1 |
| Jamin, H | 1 |
| Schneider, W | 1 |
| Atkinson, K | 2 |
| Biggs, JC | 1 |
| Golovsky, D | 1 |
| Concannon, A | 2 |
| Dodds, A | 2 |
| Downs, K | 1 |
| Ashby, M | 2 |
| Cortelazzo, S | 1 |
| Viero, P | 1 |
| D'Emilio, A | 1 |
| Rodeghiero, F | 1 |
| Sedgwick, J | 1 |
| Brostoff, S | 1 |
| Mason, D | 1 |
| Thomas, AE | 1 |
| Patterson, J | 1 |
| Prentice, HG | 1 |
| Brenner, MK | 1 |
| Ganczakowski, M | 1 |
| Hancock, JF | 1 |
| Pattinson, JK | 1 |
| Blacklock, HA | 1 |
| Hopewell, JP | 1 |
| Shaw, PJ | 1 |
| Hugh-Jones, K | 1 |
| Hobbs, JR | 1 |
| Downie, CJ | 1 |
| Barnes, R | 1 |
| Biggs, J | 1 |
| Noble, G | 1 |
| Tsygankova, VA | 1 |
| Rudakov, IA | 1 |
| Whitcomb, ME | 2 |
| Bernadou, A | 1 |
| Clauvel, JP | 1 |
| Antebi, L | 1 |
| Bilski-Pasquier, G | 1 |
| Schwarz, MI | 1 |
| Goldman, AL | 1 |
| Rorvik, TO | 1 |
| Rudowski, W | 1 |
| Klawe, Z | 1 |
| Woźniewska, M | 1 |
| Ziemski, JM | 1 |
| Jamshidi, K | 1 |
| Ansari, A | 1 |
| Windschitl, HE | 1 |
| Swaim, WR | 1 |
| Dunn, CD | 1 |
| Elson, LA | 1 |
| Ravich, RB | 1 |
| Gunz, FW | 1 |
| Thompson, IL | 1 |
| Reed, CS | 1 |
| Larbi, SO | 1 |
| Philp, RB | 1 |
| Gowdey, CW | 1 |
| Levine, J | 1 |
| Swanson, PD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mortality Due to Septic Shock Associated With Thrombocytopenia in the Intensive Care Unit[NCT03617965] | 350 participants (Anticipated) | Observational | 2018-08-15 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for busulfan and Hemorrhage
| Article | Year |
|---|---|
Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.
Topics: Adenoviridae Infections; Adenoviruses, Human; Adolescent; Adult; Aged; Anemia, Aplastic; BK Virus; B | 2003 |
Primary thrombocythemia: diagnosis, clinical manifestations and management.
Topics: Adolescent; Adult; Aged; Busulfan; Child; Diagnosis, Differential; Female; Hemorrhage; Humans; Hydro | 1993 |
Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
Topics: Adult; Aged; Aspirin; Busulfan; Double-Blind Method; Erythromelalgia; Female; Gangrene; Hemorrhage; | 1996 |
Essential thrombocythemia and pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Aspirin; Busulfan; Combined Modality Therapy; Di | 1996 |
Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers.
Topics: Adult; Aged; Alkylating Agents; Anemia, Megaloblastic; Arrhythmias, Cardiac; Bone Marrow Diseases; B | 1996 |
[Essential thrombocythemia: conventional therapy].
Topics: Adult; Antineoplastic Agents; Busulfan; Follow-Up Studies; Hemorrhage; Humans; Hydroxyurea; Immunolo | 1991 |
[Methods of studying blood thrombocytopoietic activity (literature review)].
Topics: Anemia; Animals; Blood Platelets; Blood Transfusion; Busulfan; Hemorrhage; Humans; Leukemia; Methods | 1972 |
Drug-induced lung disease.
Topics: Anti-Bacterial Agents; Anticoagulants; Antihypertensive Agents; Bleomycin; Busulfan; Chlorpropamide; | 1973 |
The spectrum of diffuse pulmonary infiltration in malignant disease.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Busulfan; Embolism, Fat; Hemorrhage; Hodgkin Disease; Humans; I | 1973 |
5 trials available for busulfan and Hemorrhage
| Article | Year |
|---|---|
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Blood Cell Count; Busulfan; Comorbidity; Disease Progres | 2014 |
Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Busulfan; Coronary Disease; Dise | 1999 |
Aspirin seems as effective as myelosuppressive agents in the prevention of rethrombosis in essential thrombocythemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Busulfan; Disease-Free Survival; Female; Hemorr | 1999 |
Relative toxicity of two different conditioning regimens in patients undergoing allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; | 1991 |
Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Catheters, Indwelling; Cyclophosphamide; C | 1991 |
35 other studies available for busulfan and Hemorrhage
| Article | Year |
|---|---|
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation.
Topics: Adult; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cyclosporine; Cystitis; Hematopoietic Stem | 2023 |
Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Allografts; Busulfan; Child; Child, Preschool; Cystitis; Female; Hematopoie | 2017 |
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
Topics: Adult; Aspirin; Bone Marrow; Busulfan; Disease Management; Disease Progression; Hemorrhage; Humans; | 2019 |
Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction.
Topics: Animals; Arthus Reaction; Blood Platelets; Busulfan; Cell Aggregation; Cell Count; Cell Movement; Ch | 2010 |
Hemorrhagic thrombocythemia. Response to busulfan.
Topics: Blood Platelets; Busulfan; Female; Hemorrhage; Humans; Postpartum Hemorrhage; Postpartum Period; Thr | 1963 |
MYLERAN AS A THERAPEUTIC ADJUNCT IN GASTROINTESTINAL BLEEDING COMPLICATING MYELOPROLIFERATIVE DISORDERS.
Topics: Anemia; Anemia, Hypochromic; Blood Platelet Disorders; Bone Marrow Diseases; Busulfan; Gastrointesti | 1963 |
[IMPROVEMENT AND EXACERBATION IN LEUKEMIA].
Topics: Aminocaproates; Aminocaproic Acid; Anemia; Antineoplastic Agents; Blood Transfusion; Busulfan; Centr | 1963 |
CHRONIC LEUKEMIA.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alkylating Agents; Anemia; Anemia, Hemolytic, | 1964 |
HAEMOPERICARDIUM IN CHRONIC MYELOID LEUKAEMIA.
Topics: Adolescent; Busulfan; Drug Therapy; Electrocardiography; Hemorrhage; Humans; India; Joint Diseases; | 1964 |
[HEMORRHAGIC THROMBOCYTHEMIA AND THE "MYELOPROLIFERATIVE SYNDROME"].
Topics: Anemia; Anemia, Hypochromic; Blood Platelets; Busulfan; Gastrointestinal Hemorrhage; Hemorrhage; Hem | 1964 |
Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.
Topics: Adolescent; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cystitis; Drug Synergism; Female; Hema | 2003 |
Busulfan-induced hemorrhagic cystitis.
Topics: Adult; Busulfan; Cystitis; Female; Hemorrhage; Humans; Leukemia, Myeloid; Time Factors; Urinary Blad | 1983 |
Busulfan-induced hemorrhagic cystitis.
Topics: Busulfan; Cystitis; Hemorrhage; Humans; Male; Middle Aged; Urinary Bladder Diseases | 1981 |
Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cystitis; Female; Hemorr | 1995 |
Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMO.
Topics: Adolescent; Africa; Anemia, Sickle Cell; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; | 1993 |
Hemorrhagic cystitis after allogeneic bone marrow transplantation for thalassemia.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Child; Child, Prescho | 1993 |
Hyperbaric oxygen in the treatment of refractory haemorrhagic cystitis.
Topics: Adenoviruses, Human; Adult; Antineoplastic Agents, Alkylating; BK Virus; Busulfan; Cyclophosphamide; | 1998 |
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients.
Topics: Acute Disease; Adult; Age Factors; Arteriosclerosis; Aspirin; Busulfan; Cohort Studies; Disease-Free | 2000 |
[The toxicity of busulphan and cyclophosphamide as the preparative regimen for allogeneic peripheral blood stem cell transplantation].
Topics: Acute Disease; Adult; Busulfan; Cyclophosphamide; Cystitis; Disease-Free Survival; Esophagitis; Fema | 2000 |
Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation.
Topics: Adenoviridae; Adenoviridae Infections; Adolescent; Adult; Aged; BK Virus; Bone Marrow Transplantatio | 2002 |
Hypofibrinogenaemia as a cause of bleeding in chronic myeloid leukaemia.
Topics: Afibrinogenemia; Aged; Blood Cell Count; Bone Marrow Cells; Busulfan; Chronic Disease; Disseminated | 1975 |
Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
Topics: Bloodletting; Busulfan; Cause of Death; Hemorrhage; Humans; Incidence; Leukemia, Myelogenous, Chroni | 1991 |
Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Busulfan; Cohort Studies; Female; Follow-Up Studies; Hem | 1990 |
Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system.
Topics: Animals; Busulfan; Cells, Cultured; Central Nervous System; Cerebral Hemorrhage; Chlorambucil; Encep | 1987 |
Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; | 1987 |
Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children.
Topics: Adolescent; Bone Marrow; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosph | 1986 |
Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Cystitis; Hemorrhage; Hepatic Veno-Occlusiv | 1987 |
[Vaquez's diseas. Clinical and developmental study. Apropos of 144 cases].
Topics: Adult; Arteriosclerosis; Arteritis; Blood Sedimentation; Busulfan; Child; Erythrocyte Count; Female; | 1968 |
[Polycythemia vera].
Topics: Busulfan; Chronic Disease; Diagnosis, Differential; Hemorrhage; Humans; Phosphorus Radioisotopes; Po | 1974 |
Major surgery in patients with polycythaemia vera.
Topics: Aged; Blood Platelets; Blood Transfusion, Autologous; Bloodletting; Busulfan; Erythrocyte Count; Fem | 1974 |
Primary thrombocythemia.
Topics: Adult; Aged; Blood Coagulation Tests; Bone Marrow Examination; Busulfan; Follow-Up Studies; Gastroin | 1973 |
Quantitative studies of haemopoietic spleen colonies in rats treated with cytotoxic chemicals.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Chlorambucil; Female | 1970 |
The dangers of surgery in uncontrolled haemorrhagic thrombocythaemia.
Topics: Aged; Blood Cell Count; Blood Platelets; Busulfan; Hemorrhage; Humans; Male; Middle Aged; Peptic Ulc | 1970 |
The effects of alkoxyglycerols on haematopoiesis.
Topics: Anemia; Animals; Benzene; Blood Cell Count; Busulfan; Chlorambucil; Erythrocyte Count; Female; Hemat | 1968 |
Idiopathic thrombocytosis. A treatable cause of transient ischemic attacks.
Topics: Adult; Blood Platelet Disorders; Busulfan; Female; Hemorrhage; Humans; Hyperplasia; Ischemic Attack, | 1968 |